Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
Crossref DOI link: https://doi.org/10.1007/s40258-019-00548-6
Published Online: 2020-01-14
Published Print: 2020-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Michels, Renée Else
De Francesco, Maria
Mahajan, Koshu
Hengstman, Gerald J. D.
Schiffers, Krijn M. H.
Budhia, Sangeeta
Harty, Gerard
Krol, Marieke http://orcid.org/0000-0002-6153-0828
Text and Data Mining valid from 2020-01-14
Version of Record valid from 2020-01-14
Article History
First Online: 14 January 2020